PRTG: Gunggung dhuwit awis saben saham portagebiotech.com

Lambang korporat lan logo Portage Biotech Inc. (PRTG)

Portage Biotech Inc. (PRTG) relies on a virtual model, outsourcing molecule synthesis to external contractors. Value growth is expected from tests of iNKT agonists in combination with inhibitors. However, the lack of sales and research expenses are hindering scaling. This chart from GURU.Markets showing cash per share confirms these data, with the current level equal to 0.78.

PRTG: Dhuwit awis saben saham Portage Biotech Inc 04.07.2022 - 04.09.2025

Rincian analitis perusahaan Portage Biotech Inc.

- rega pasar lan target rega analis:
- rincian posisi dhuwit lan arus kas:
Ringkesan analisis perusahaan:PRTG, Portage Biotech Corp
Produk asli portagebiotech.com

The suspension of several studies by Portage Biotech Inc. (PRTG) is driven by the need to preserve capital until the commercialization of its drugs. This strategy directly impacts the ratio of net cash to shares outstanding. This metric measures the portion of liquid reserves available to each shareholder to ensure operational stability. While a decrease in this indicator typically signifies investments in expansion, here it signals a risk of capital depletion. The current level of liquidity per share clearly demonstrates the rate of resource burn.